Molina Healthcare, Inc $MOH Shares Sold by Asset Management One Co. Ltd.

Key Points

• Asset Management One cut its stake in Molina by 91.6%, selling 20,829 shares and leaving it with 1,908 shares worth about $318,000.
• Q1 EPS beat: Molina reported $2.35 EPS versus $1.57 expected and reaffirmed FY‑2026 guidance of ~$5.00 adjusted EPS, but revenue and membership fell as the company exits unprofitable MAPD business, prompting mixed analyst reactions.
• Institutional ownership is concentrated at 98.5%, with large managers (AQR, Victory, Dimensional, UBS) significantly increasing positions, while the street consensus is a "Hold" with an average price target near $160.07.

Asset Management One Co. Ltd. lessened its holdings in shares of Molina Healthcare, Inc (NYSE:MOH - Free Report) by 91.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 1,908 shares of the company's stock after selling 20,829 shares during the quarter. Asset Management One Co. Ltd.'s holdings in Molina Healthcare were worth $318,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors also recently modified their holdings of the company. AQR Capital Management LLC raised its position in shares of Molina Healthcare by 217.0% during the third quarter. AQR Capital Management LLC now owns 2,934,130 shares of the company's stock worth $561,475,000 after purchasing an additional 2,008,458 shares during the period. Victory Capital Management Inc. boosted its stake in shares of Molina Healthcare by 344.3% during the 3rd quarter. Victory Capital Management Inc. now owns 963,526 shares of the company's stock worth $184,380,000 after acquiring an additional 746,639 shares in the last quarter. Dimensional Fund Advisors LP boosted its stake in shares of Molina Healthcare by 31.0% during the 3rd quarter. Dimensional Fund Advisors LP now owns 938,677 shares of the company's stock worth $179,632,000 after acquiring an additional 222,346 shares in the last quarter. UBS Group AG boosted its stake in shares of Molina Healthcare by 320.7% during the 3rd quarter. UBS Group AG now owns 603,934 shares of the company's stock worth $115,569,000 after acquiring an additional 460,372 shares in the last quarter. Finally, Northern Trust Corp boosted its stake in shares of Molina Healthcare by 4.9% during the 3rd quarter. Northern Trust Corp now owns 569,023 shares of the company's stock worth $108,888,000 after acquiring an additional 26,355 shares in the last quarter. Institutional investors own 98.50% of the company's stock.

Molina Healthcare Price Performance

NYSE:MOH opened at $175.89 on Friday. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.69 and a current ratio of 1.63. The stock's 50-day simple moving average is $145.92 and its 200 day simple moving average is $159.28. The company has a market cap of $9.16 billion, a P/E ratio of 52.04 and a beta of 0.55. Molina Healthcare, Inc has a 52-week low of $121.06 and a 52-week high of $333.00.

Molina Healthcare (NYSE:MOH - Get Free Report) last released its earnings results on Wednesday, April 22nd. The company reported $2.35 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.57 by $0.78. The business had revenue of $10.80 billion for the quarter, compared to the consensus estimate of $10.91 billion. Molina Healthcare had a return on equity of 8.76% and a net margin of 0.42%.Molina Healthcare's quarterly revenue was down 3.1% on a year-over-year basis. During the same quarter in the previous year, the business earned $6.08 earnings per share. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. As a group, sell-side analysts forecast that Molina Healthcare, Inc will post 5.04 EPS for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms recently weighed in on MOH. Wells Fargo & Company set a $141.00 price objective on Molina Healthcare and gave the stock an "equal weight" rating in a research report on Friday, February 20th. UBS Group increased their target price on Molina Healthcare from $151.00 to $180.00 and gave the stock a "neutral" rating in a report on Friday. Weiss Ratings reissued a "sell (d+)" rating on shares of Molina Healthcare in a report on Tuesday. Barclays raised their price target on Molina Healthcare from $133.00 to $161.00 and gave the company an "underweight" rating in a report on Friday. Finally, Sanford C. Bernstein reiterated an "outperform" rating on shares of Molina Healthcare in a research report on Friday, March 13th. Two equities research analysts have rated the stock with a Buy rating, eleven have issued a Hold rating and two have assigned a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of "Hold" and an average price target of $160.07.

Trending Headlines about Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Q1 EPS beat and FY26 guidance reaffirmed: Molina reported $2.35 EPS vs. $1.57 expected and kept FY26 guidance of at least $5.00 adjusted EPS and ~$42B in premium revenue — a clear near‑term positive for sentiment and valuation. Article Title
• Positive Sentiment: Cost control and MA‑Part D exit improve earnings quality: Management highlighted lower medical costs and is exiting unprofitable MAPD business (removing roughly $1B of revenue), which should boost margins and normalized earnings power per company commentary and analyst write‑ups. Article Title
• Neutral Sentiment: Earnings call details and analyst notes are mixed: Transcripts and recaps emphasize the tradeoff between profitability gains and top‑line shrinkage; some analysts are upgrading sentiment while others remain cautious. Article Title
• Neutral Sentiment: Coverage shows investor reactions and market commentary: Multiple outlets explain the big intraday move as a reaction to the beat + strategic exit, providing context but not new financials. Article Title
• Negative Sentiment: Revenue and membership declined: Q1 revenue came in roughly $10.8B (slightly below some estimates) and membership fell, reflecting the business shrinkage from the MAPD exit and lower premiums — headwinds for growth. Article Title
• Negative Sentiment: Profitability still depressed vs. year‑ago: Net income and EPS remain well below last year’s levels (profits down materially year‑over‑year), leaving investors wary that underlying normalized earnings improvement will take time. Article Title
• Negative Sentiment: Medicaid spending and market share uncertainty: Commentators note uncertainty around future Medicaid costs and whether Molina can regain membership/share, keeping analyst ratings mixed and limiting visibility on sustained margin improvements. Article Title
• Neutral Sentiment: Analysts are conflicted: Coverage highlights split views — some see a cleaner, higher‑quality earnings stream post‑MAPD exit, others worry the revenue shrink and Medicaid risks justify caution. Article Title

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.